TaiMed Biologics Inc (中裕新藥) yesterday dismissed speculation that it is having financial difficulties because of declining sales of its Trogarzo HIV treatment in the US.
The company’s shares closed 5.21 percent lower at NT$94.60 yesterday on the Taipei Exchange. They have plummeted 42.84 percent this year, trailing the over-the-counter market’s advance of 19.05 percent.
The decline accelerated after TaiMed CEO James Chang (張念原) told an investors’ conference on Wednesday last week that Trogarzo’s sales momentum in the US was weaker than expected, and that the number of patients taking Trogarzo in the US is likely to reach just 400 at the end of this year, lower than its estimate of between 700 and 800.
Taimed’s marketing partner, Theratechnologies Inc, has deferred orders to next year due to high inventories, and the company now expects sales to peak in six years instead of four, Chang said.
“Chang shared why sales were weaker than expected, but he also said he was upbeat that sales would improve next year. However, rumors surfaced the next day — that TaiMed is facing financial trouble or that it is bound to shut down,” TaiMed chief financial officer Jack Chen (陳怡成) told the Taipei Times by telephone.
TaiMed has taken numerous calls from investors asking for an explanation, Chen said.
According to postings on the stock investment online forum Berich (必富網), some investors said they have suffered huge losses after they bought the stock at more than NT$300 a share, while others said they felt pessimistic about the company’s outlook.
“It would take time for sales to boom as our drug is new and a fourth-line treatment,” Chen said, adding that sales are expected to improve next year.
Theratechnologies is expected to solve the inventory issue in the short term, he said.
TaiMed has free cash flow of more than NT$1.6 billion and gross margin improved to 40 percent last quarter, he said.
TECH PARTNERSHIP: The deal with Arizona-based Amkor would provide TSMC with advanced packing and test capacities, a requirement to serve US customers Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) is collaborating with Amkor Technology Inc to provide local advanced packaging and test capacities in Arizona to address customer requirements for geographical flexibility in chip manufacturing. As part of the agreement, TSMC, the world’s biggest contract chipmaker, would contract turnkey advanced packaging and test services from Amkor at their planned facility in Peoria, Arizona, a joint statement released yesterday said. TSMC would leverage these services to support its customers, particularly those using TSMC’s advanced wafer fabrication facilities in Phoenix, Arizona, it said. The companies would jointly define the specific packaging technologies, such as TSMC’s Integrated
China’s economic planning agency yesterday outlined details of measures aimed at boosting the economy, but refrained from major spending initiatives. The piecemeal nature of the plans announced yesterday appeared to disappoint investors who were hoping for bolder moves, and the Shanghai Composite Index gave up a 10 percent initial gain as markets reopened after a weeklong holiday to end 4.59 percent higher, while Hong Kong’s Hang Seng Index dived 9.41 percent. Chinese National Development and Reform Commission Chairman Zheng Shanjie (鄭珊潔) said the government would frontload 100 billion yuan (US$14.2 billion) in spending from the government’s budget for next year in addition
Sales RecORD: Hon Hai’s consolidated sales rose by about 20 percent last quarter, while Largan, another Apple supplier, saw quarterly sales increase by 17 percent IPhone assembler Hon Hai Precision Industry Co (鴻海精密) on Saturday reported its highest-ever quarterly sales for the third quarter on the back of solid global demand for artificial intelligence (AI) servers. Hon Hai, also known as Foxconn Technology Group (富士康科技集團) globally, said it posted NT$1.85 trillion (US$57.93 billion) in consolidated sales in the July-to-September quarter, up 19.46 percent from the previous quarter and up 20.15 percent from a year earlier. The figure beat the previous third-quarter high of NT$1.74 trillion recorded in 2022, company data showed. Due to rising demand for AI, Hon Hai said its cloud and networking division enjoyed strong sales
Protectionism: US trade chief Katherine Tai said the hikes would help to counter unfair trade practices from China, while boosting domestic clean energy investments US Trade Representative Katherine Tai (戴琪) defended stiff tariff hikes against countries such as China, saying that paired with investment, they were a “legitimate and constructive” tool for reinvigorating domestic industries. Tai’s comments come a week after sharp tariff increases on Chinese electric vehicles (EVs), EV batteries and solar cells took effect — with levies down the line on other products also recently finalized. The latest moves targeting US$18 billion in Chinese goods come weeks before next month’s US presidential election, with Democrats and Republicans pushing a hard line on China as competition between Washington and Beijing intensifies. In an interview on Thursday
RSS